"ESCAPE MAPPING". I use this in every AF ablation case.. makes touching up PVI gaps much easier than what I used to do. Pace from the ablator and make your CS as reference. Then just look for the purple breakthrough! #AFablation@thejvandoren
I started building an #LBBAP simulator for my own learning with @claudeai and got a bit carried away.
Free to use: https://t.co/PSMURUTG54
Inspired by https://t.co/e65RlkE0Rw and https://t.co/IQcb0HKjag. Check it out. All feedback welcome!
#EPeeps#LBBAP#cardiotwitter
I started building an #LBBAP simulator for my own learning with @claudeai and got a bit carried away.
Free to use: https://t.co/PSMURUTG54
Inspired by https://t.co/e65RlkE0Rw and https://t.co/IQcb0HKjag. Check it out. All feedback welcome!
#EPeeps#LBBAP#cardiotwitter
Now published online!
Recommendations for nuanced AAD management, including:
Use of 1Cs in stable CAD?
Restarting dofetilide/sotalol without hospitalization?
AAD interactions with other drugs and CIEDS.
…+ 46 other recommendations.
#epeeps@EPeeps_Bot@HRSonline
Two needed studies this week that confirm limited (if any) role of angiography and PCI to manage/mitigate ventricular arrhythmias in HF (REVIVED-BCIS2) @CircAHA and monomorphic VT storm (Cleveland Clinic registry) @JACCJournals.
https://t.co/YdzgZUXAWA
https://t.co/YR438viIe4
PSA: Reflexive trips to the Cath Lab deserve to be questioned in arrhythmia risk management.
Discontinuation of OACs in patients with AF postablation did not affect the overall TE incidence but was associated with a ⬇️ in major bleeding events. However, there was a significant ⬆️ in TE risk in patients with a CHA2DS2-VASc score >2 upon discontinuation.
#EPeeps
Hot off the press! We showed that increasing number of PFA applications for AF is associated with reduced arrhythmia recurrence without affecting procedure times or complication rate.
#CardioTwitter@FYang_EP@CRB_EP@ExtraStim@DavidParkLab1@LarryChinitz https://t.co/xncl7KppMP
Excited to share this new book on Cardiac CT!
Forever grateful to Dr. Braunwald who asked me to write this and for his guidance and mentorship along the way. While we are mourning his recent passing, I will treasure all the conversations I had with him on #CCT and #Prevention
(1) We have cases where PVCs are not produced on the table, particularly after sedation. @drrakeshg1 and I were able to prove a theory I have held for years regarding the MOA of outflow tract PVCs. Our workflow allows for identification of the trigger site when PVCs are absent.
📢 NEW FDA APPROVAL marks a milestone for #PFA.
Introducing the FARAPOINT™ Pulsed Field Ablation (PFA) Catheter—the first and only focal catheter designed and optimized for PFA—built on the proven FARAPULSE™ PFA Platform. FARAPOINT creates deep, durable focal and linear-shaped lesions in a single catheter, unlocking new possibilities for optimized point-by-point workflows for CTI ablations.
Explore FARAPOINT: https://t.co/rKkllURy92
#Epeeps #PulsedFieldAblation
FARAPULSE™ Pulsed Field Ablation System Indications, Safety, and Warnings: https://t.co/A64fZE9GVn
OPAL HDx™ Mapping System Indications, Safety, and Warnings: https://t.co/wu777PHkBb
4/10 – Inverted Mapping of Accessory Pathways
*⃣A Bordeaux-led study updates the “inverted mapping” concept using modern 3D mapping + pacing techniques.
🌟Highlights:
➡️Targets the ventricular insertion by finding the shortest stim-to-A interval during ventricular pacing.
➡️Works especially well for oblique, epicardial, or concealed pathways.
➡️Increased precision in cases where AP potentials are elusive.
🧑🎓This paper combines EP maneuvers with state-of-the-art mapping, producing a powerful tool for complex AP ablations.
https://t.co/8xltjmpcxm